Korro Bio, Inc.KRRO
Price (close)
$9.57
Market cap
$140.7M
P/E
—
Revenue (TTM)
$2.4M
Net income
-$106.6M
Dividend yield
—
1-year total return
-74.9%
Net margin
-4477.1%
Revenue growth
-62.1%
Debt / equity
—
What Korro Bio, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $37.0M | $14.1M | $0 | $0 | $2.3M | $6.4M |
| Net income | -$26.5M | -$84.7M | -$58.0M | -$81.2M | -$83.6M | -$117.3M |
| Free cash flow | -$51.9M | -$79.0M | -$58.8M | -$75.1M | -$78.0M | -$79.1M |
More on KRRO.
- Korro Bio, Inc. summary
- Korro Bio, Inc. financial statements
- Korro Bio, Inc. key metrics
- Korro Bio, Inc. health scores and style box
- Korro Bio, Inc. earnings
- Korro Bio, Inc. dividends
- Korro Bio, Inc. valuation
- Korro Bio, Inc. ownership and insiders
- Korro Bio, Inc. peers
Figures from Korro Bio, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.